DEFICIENT ACTIVITY OF VON-WILLEBRAND FACTOR-CLEAVING PROTEASE IN CHRONIC RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA

Citation
M. Furlan et al., DEFICIENT ACTIVITY OF VON-WILLEBRAND FACTOR-CLEAVING PROTEASE IN CHRONIC RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA, Blood, 89(9), 1997, pp. 3097-3103
Citations number
28
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
89
Issue
9
Year of publication
1997
Pages
3097 - 3103
Database
ISI
SICI code
0006-4971(1997)89:9<3097:DAOVFP>2.0.ZU;2-M
Abstract
In patients with thrombotic thrombocytopenic purpura (TTP), excessive intravascular platelet aggregation has been associated with appearance in plasma of unusually large von Willebrand factor (VWF) multimers. T hese extremely adhesive vWF multimers may arise due to deficiency of a ''depolymerase'' cleaving vWF to smaller molecular forms, either by r educing the interdimeric disulfide bridges or by proteolytic degradati on, We studied the activity of a recently described vWF-cleaving prote ase in four patients with chronic relapsing TIP. Diluted plasma sample s of TTP patients were incubated with purified normal human vWF in the presence of a serine protease inhibitor, at low ionic strength, and i n the presence of urea and barium ions. The extent of vWF degradation was assayed by electrophoresis in sodium dodecyl sulfate-agarose gels and immunoblotting. Four patients, that included two brothers, with ch ronic relapsing TTP displayed either substantially reduced levels or a complete absence of vWF-cleaving protease activity, In none of these patient plasmas was an inhibitor of or an antibody against the vWF-cle aving protease established. Our data suggest that the unusually large vWF multimers found in TTP patients may be caused by deficient vWF-cle aving protease activity. Deficiency of this protease may be inherited in an autosomal recessive manner and seems to predispose to chronic re lapsing TTP. The assay of the vWF-cleaving protease activity may be us ed as a sensitive diagnostic tool for identification of subjects with a latent TTP tendency. (C) 1997 by The American Society of Hematology.